ADHD Medication Follow-Up Visits in New York: How Often

Updated October 13, 2026. Part of the New York Adult ADHD Guide, weigh your options section. Medically reviewed by John C. Shershow, M.D. on October 13, 2026. Editorial policy

Key points

Under 10 NYCRR 80.63(d), the prescriber determines the frequency of future evaluations using generally accepted medical standards, and New York sets no fixed follow-up interval.
Schedule II stimulants cannot be refilled in New York, and the base supply limit is 30 days.
New York permits up to a three-month supply for attention deficit disorder when the condition or its code is on the prescription, at the prescriber's discretion.
As of October 13, 2026, no US clinical practice guideline specific to adult ADHD had been published.
Under federal law, once a prescriber has done one in-person evaluation, that prescriber may prescribe remotely to the patient indefinitely if other legal requirements are met.

New York does not set a schedule for ADHD follow-up visits. No statute or regulation says monthly, quarterly or yearly. What the state does regulate is the prescription: how much can be dispensed at once, that it cannot be refilled, and what the prescriber must do each time a new one is written. Visit frequency is left to the prescriber's clinical judgment, and in practice it is shaped by four things: the supply rules, the stage of treatment, your insurance, and the practice's own policy.

What each rule requires, and what it leaves open

Source	What it says	Effect on how often you are seen
10 NYCRR 80.63(d)	The practitioner determines the "frequency of future medical evaluations" using "generally accepted medical standards," taking into account the drug, the patient's condition and history, and disposition toward the use of controlled substances.	No fixed interval. The prescriber decides, patient by patient.
10 NYCRR 80.67(a) and (c)	Schedule II prescriptions cannot be refilled. The base limit is a 30-day supply.	On 30-day supplies, the prescriber writes at least twelve prescriptions a year. Each is a point of contact with the practice, though not necessarily a visit.
10 NYCRR 80.67(d)	For attention deficit disorder, up to a three-month supply may be prescribed when the condition or its code appears on the prescription.	As few as four prescriptions a year, if the prescriber, insurer and pharmacy all agree.
10 NYCRR 80.63(c)	The prescriber must consult the Prescription Monitoring Program registry no more than 24 hours before each controlled-substance prescription.	Every prescription involves a deliberate act by the prescriber. Nothing renews automatically.
Federal DEA telemedicine flexibilities	Through December 31, 2026, Schedule II medication may be prescribed after audio-video visits without a prior in-person evaluation.	Follow-ups can lawfully be by video as of October 2026.

A prescription and a visit are different events. The rules above govern prescriptions. A prescriber may write a new monthly prescription between visits for a patient who is stable and recently seen, or may require a visit for every prescription. Both are within the regulation. Ask which approach a practice uses before you start.

What the guidelines say

As of October 13, 2026, the United States has no published clinical practice guideline specific to adult ADHD. The American Professional Society of ADHD and Related Disorders announced in August 2026 that its guideline had entered final review, with publication anticipated in the fall. Until it appears, there is no American guideline number to quote for follow-up intervals, and anyone who cites one should be asked for the source.

What the published literature does support is the content of follow-up. The American Family Physician review of adult ADHD advises prescription monitoring program checks and controlled-substance agreements to watch for misuse or diversion. A large Swedish registry study in JAMA Psychiatry associated longer cumulative use of ADHD medication with modestly higher rates of hypertension and arterial disease, which is the reason blood pressure and pulse are followed over time. The boxed warning on stimulant labels tells prescribers to assess each patient's risk of misuse and to educate patients about storage and disposal.

Why visits are closer together at some times than others

Because the regulation ties frequency to the drug and to the individual patient, expect the interval to move.

Closer together: starting a medication, changing the dose or formulation, new side effects, a rising blood pressure reading, a new medical diagnosis or medication, pregnancy or planning for it, a co-occurring condition that is not yet stable, a history of substance use, or a lost or early-fill request.
Further apart: the same medication and dose for several months, steady vital signs, no new health issues, and prescriptions filled on schedule.

What the early visits cover is described in starting ADHD medication, what the first three months involve.

Three common arrangements compared

Arrangement	How it works	Advantages	Drawbacks
A visit with every 30-day prescription	You are seen each month and leave with one prescription.	Problems are caught early. Simple for the pharmacy and insurer.	Twelve visits a year in time and visit fees. A missed appointment can mean a gap.
Visits every two or three months, with a new 30-day prescription issued in between on request	You request each prescription when you are down to about a week's supply. The prescriber checks the registry and sends it.	Fewer visits. Monthly quantities are easier for a pharmacy to stock.	You have to remember to request it inside a narrow window each month.
Visits about every three months with a single three-month supply	One prescription marked for attention deficit disorder covers up to three months.	Fewest pharmacy trips. Useful for travel.	Insurers and pharmacies may refuse the quantity. More medication to store securely. If it is lost or stolen, a replacement is not guaranteed and insurance may not pay for one.

The three-month supply is a ceiling that the regulation permits, and nobody is entitled to it. A prescriber may decline it for clinical reasons, and a plan's quantity limit can override it in practice. The supply rules are set out in full in New York's rules for ADHD stimulant prescriptions.

Video or in-person follow-ups

As of October 2026, follow-up visits for stimulant treatment may be by audio-video telehealth in New York, because the state rule defers to federal DEA rules and the federal flexibilities run through December 31, 2026. No final federal rule for 2027 had been published when this page was written.

One point in the federal notice is worth knowing. Under the underlying federal law, once a prescriber has conducted one in-person medical evaluation of a patient, that prescriber may prescribe remotely to that patient indefinitely, as long as prescriptions are for a legitimate medical purpose and comply with other law. A single in-person visit with your prescriber is therefore the most dependable hedge against a change in 2027, although the final rule had not been published and could add conditions.

Different rules apply in neighboring systems:

Patients located in New Jersey: since July 8, 2026, state law requires a contact every three months (in person or by telehealth) and an in-person visit at least once a year for adults on a Schedule II stimulant. See living in New Jersey, getting ADHD care in New York.
Medicare: the payment rule requiring an in-person visit in connection with mental health telehealth is delayed and applies to services after December 31, 2027, unless Congress acts again. This is a Medicare payment rule and is separate from the DEA prescribing rule.
New York-regulated commercial plans: state law requires covered telehealth visits to be reimbursed on the same basis as in-person visits, under provisions currently effective until April 1, 2028. Self-funded employer plans are outside that law.

Questions that settle it for your case

How often will you want to see me in the first three months, and after that if I am stable?
Do you issue prescriptions between visits, and how do I request one?
Do you write three-month supplies for stable patients, and does my plan allow that quantity?
Are follow-ups by video, in person, or my choice?
If federal telehealth rules change in 2027, will I need an in-person visit, and where?
What does each follow-up cost, and which billing code do you use?

How follow-up and medication management work at this practice is described under adult ADHD treatment, and visit formats are on the appointments and telehealth page. For the full list to use on a first call, see questions to ask before you book an adult ADHD evaluation.

Questions

Does New York require a doctor visit every month for ADHD medication?

No. New York requires a new prescription for every fill because Schedule II drugs have no refills, but it does not require a visit for each prescription. The prescriber decides how often to see you.

Can I get a 90-day supply so I only need four visits a year?

New York allows up to a three-month supply for attention deficit disorder, so it is legally possible. The prescriber may decline, and insurers and pharmacies often limit quantities to 30 days. Ask both the practice and your plan.

Why does my prescriber want to see me more often than my friend's does?

The regulation tells prescribers to take into account the drug, the patient's condition and history. Someone who has just started or changed medication, or who has other health conditions, is reasonably seen more often than someone stable for years. Practices also set their own policies.

Can all my follow-up visits be by video?

As of October 2026, yes under New York and federal rules, which run through December 31, 2026 on the federal side. What applies afterward had not been published when this page was written. Patients located in New Jersey need an in-person visit at least once a year.

What happens at an ADHD medication follow-up visit?

The prescriber typically reviews how well the medication is working, side effects, sleep, appetite, blood pressure and pulse, and any changes in your health or other medications. Before writing the next prescription the prescriber must check the state prescription registry.

Sources

This article is general information, not medical or legal advice. Rules and coverage change; check the linked sources for the current position, and speak with a clinician or attorney about your own situation.

How often you need follow-up visits for ADHD medication in New York